General Information of the Compound
| Compound ID |
CP0423064
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[[2-[2-(4-bromoanilino)-2-oxoethyl]-6-methyl-3-oxopyridazin-4-yl]methyl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H19BrN4O3
|
||||||||||||||||||
| Molecular Weight |
455.312
|
||||||||||||||||||
| Canonical SMILES |
Cc1cc(Cc2ccc(cc2)C(N)=O)c(=O)n(CC(=O)Nc2ccc(Br)cc2)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H19BrN4O3/c1-13-10-16(11-14-2-4-15(5-3-14)20(23)28)21(29)26(25-13)12-19(27)24-18-8-6-17(22)7-9-18/h2-10H,11-12H2,1H3,(H2,23,28)(H,24,27)
Show/Hide
|
||||||||||||||||||
| InChIKey |
IMSKONLMQRQUQO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02015, fMet-Leu-Phe receptor
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2